Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency - Wikidata - wikimedia - TriplyDB

Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency

Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency

http://www.wikidata.org/entity/Q35979202

about

Leukotoxin diols from ground corncob bedding disrupt estrous cyclicity in rats and stimulate MCF-7 breast cancer cell proliferation.Development of a cell-based bioassay for phospholipase A2-triggered liposomal drug release Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers Enhancement of paclitaxel activity against hormone-refractory prostate cancer cells in vitro and in vivo by quinacrine.Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease Inhibitory effect of cisplatin and [Pt(dach)Cl2] on the activity of phospholipase A2.Peptidophospholipids: synthesis, phospholipase A2 catalyzed hydrolysis, and application to development of phospholipid prodrugs.Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats Secreted PLA2 induces proliferation in astrocytoma through the EGF receptor: another inflammation-cancer link.Platelet-activating factor and metastasis: calcium-independent phospholipase A2β deficiency protects against breast cancer metastasis to the lung.Group II and IV phospholipase A(2) are produced in human pancreatic cancer cells and influence prognosis.Secretory phospholipase A₂ responsive liposomes.Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factor Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver.Tetrahydrofurandiol stimulation of phospholipase A2, lipoxygenase, and cyclooxygenase gene expression and MCF-7 human breast cancer cell proliferation Expression of secreted phospholipase A2-Group IIA correlates with prognosis of gastric adenocarcinoma.Molecular Imaging of Cancer: Applications of Magnetic Resonance Methods.Discrimination between adenocarcinoma and normal pancreatic ductal fluid by proteomic and glycomic analysis.The role of phosphatidylcholine and choline metabolites to cell proliferation and survival.Strategies for triggered drug release from tumor targeted liposomes.Synthesis of lipids for development of multifunctional lipid-based drug-carriers.Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs.Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer.Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis.Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.Cyclooxygenase-2 gene expression is upregulated in transformed mammary epithelial cells.Antitumoral effects of γCdcPLI, a PLA2 inhibitor from Crotalus durissus collilineatus via PI3K/Akt pathway on MDA-MB-231 breast cancer cell.The expression of phospholipase A2 group X is inversely associated with metastasis in colorectal cancer.Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis.Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2.Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women.Immunohistochemical analysis of expressions of RB1, CDK4, HSP90, cPLA2G4A, and CHMP2B is helpful in distinction between myxofibrosarcoma and myxoid liposarcoma.

P2860

Q24811687-C26976B5-0B34-47AB-A660-134A896B1140 Q28547031-2B102E72-DC0D-4424-B931-53064C108A03 Q28743513-EC8D042E-C7C9-4EA7-BCA9-9ADCEAA17706 Q30438658-952A21BB-C9CB-4107-8EAB-9AB786D29CB7 Q30514230-A6BC20B7-2C16-41E3-8D26-6DA5CD49D2CF Q33815876-7F94BCDA-4407-4DAD-BC89-481E19E8BD9A Q33923169-4CC30557-E7EC-468C-95CD-2760E66CD7C1 Q34198269-DE0F1D99-B7C2-4145-867A-0D9826397779 Q34282797-9FC175D0-3C82-4E5A-9210-D10B4AEBBE1C Q34409188-0A9EEA4F-AB6B-49B9-BFB7-EACF1716D572 Q34480613-786FCC6B-F58C-44EA-ABDD-B9215466BB70 Q34782186-39336B42-12E2-44FC-8978-23C5B8032769 Q35357077-98921FA0-0D3E-4339-87C7-05E9D0FFC079 Q35385515-68A205F7-6277-4585-ACCF-8C5180777A96 Q35763079-BBF30644-0DBC-45B9-96FB-5C306487267F Q35786754-68A4FEAA-B4B9-472D-B9A3-E317B08F2C41 Q36264601-842DE2CB-92C1-4C3C-B9EF-D9FC0EE32324 Q36335600-60B234D1-A00B-4797-B9E0-550AFF016665 Q37359297-836ACC9A-F6CD-44E6-AF5C-679B6B50D168 Q37624230-475BC99B-3C27-4064-8CBC-316F8A4D3ED5 Q38076754-97AAFA83-BCDB-432D-95BA-693944D866C0 Q38116638-469FE9EE-40E5-4EE7-AC2C-1F3B015D41A5 Q38733163-84EA9876-62AE-4C86-93C5-BF3EB5A3F96D Q39136980-45087859-9EB5-4133-B30D-F677B7B23892 Q39297921-1AB6817F-42E8-4D80-AD9B-345BFCD62386 Q39335230-0E9C4C32-3313-4DA2-946F-1D92F205EDF3 Q39393558-C388EAFE-A7E2-4A01-9528-352371D00EFD Q40679478-EEE7E1BB-639E-41C8-8DCB-BD1FCA8EF31B Q41036461-19E724D4-7E73-4F05-89BE-BBFE45257745 Q41203587-3F1DC50E-038B-4B8E-AA1B-9F351FFA86C3 Q43247211-565362FA-A0D8-4C1E-A221-C85FA8BBB194 Q45929037-C37FC5F6-E644-402F-8BD8-9968506B6645 Q46953962-28359DD4-9E8C-4B9E-9B98-FEEEBB5BE2E9 Q50041769-91E82473-745A-4BE7-A4A7-FDA1A3911C26 Q54355782-7AFE9D0A-C997-48A0-9074-538482C66DDD

P2860

Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency

http://www.wikidata.org/entity/Q35979202

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

1994年论文

@zh

1994年论文

@zh-cn

name

Overexpression of group II pho ...... d with their malignant potency

@ast

Overexpression of group II pho ...... d with their malignant potency

@en

type

label

Overexpression of group II pho ...... d with their malignant potency

@ast

Overexpression of group II pho ...... d with their malignant potency

@en

prefLabel

Overexpression of group II pho ...... d with their malignant potency

@ast

Overexpression of group II pho ...... d with their malignant potency

@en

P1433

Q35979202-C77A7142-D8CE-4812-8E20-F618896DE008

P1476

Q35979202-A98A7509-6676-49A6-A78F-0FE97FAB1EB4

P2093

Q35979202-3F57A7EB-E87C-4C26-8C3A-37B56A6DA789

Q35979202-5958712B-81A4-4A47-83AC-BC3D22577604

Q35979202-9E051F43-EFF3-444F-8BC9-4AE410D8ECA9

P2860

Q35979202-2648F124-F026-45C3-8C9B-BC1D456BF4CF

Q35979202-26E8018A-CC22-4261-BC87-0C852CB44313

Q35979202-2B41D4A4-AADB-4916-8952-A936FAC20A23

Q35979202-30342CFE-7EEC-481B-8190-B1F305EA26BF

Q35979202-3851C6E8-6F77-4F5B-817F-21A72E3B1E24

Q35979202-3B43E4C9-1E25-4B2F-9EF6-B615E4FAB801

Q35979202-41A1DF04-1613-4EDB-A534-5DFCDF6A2734

Q35979202-4C4604BD-2E22-4964-AFF1-700735BCF320

Q35979202-4CAEA6BB-E4DF-47B6-A780-7E3C9C36EE1B

Q35979202-521C2464-8EA8-4D27-916D-8E5651011BB8

P2888

Q35979202-210DDD35-FC05-41BD-9BE7-DDDE2A23882F

P304

Q35979202-31B0D035-9F23-4CB3-9BA6-F65FF914C22E

P31

Q35979202-FCF4B795-5105-418C-950D-BBF0F70E4D48

P356

Q35979202-C4A0C9A5-6862-462F-B0A6-52B8E08D147B

P407

Q35979202-0C594668-E517-4BFA-A048-E3AA1174A4DE

P433

Q35979202-DE57D1B2-B649-4A8D-AFF8-2817D37D3044

P478

Q35979202-48EB4C26-4035-40F4-9D14-7EECF3043A85

P577

Q35979202-8A9604C6-5684-48C9-BA0B-02E6EDDAEDEE

P5875

Q35979202-56CA9254-C2D2-42AA-A830-CBD766D17A18

P698

Q35979202-13356429-D1F2-4A56-92FE-4B69C4BDDC90

P921

Q35979202-A219DBB3-3694-46F5-AA5E-9415F3AFDB94

P932

Q35979202-49994C95-B75D-4768-BBD2-40A6BD391E3D

P356

P1433

British Journal of Cancer

P1476

Overexpression of group II pho ...... d with their malignant potency

@en

P2093

J Yamashita

http://www.w3.org/2001/XMLSchema#string

M Ogawa

http://www.w3.org/2001/XMLSchema#string

S Yamashita

http://www.w3.org/2001/XMLSchema#string

P2860

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid

Preparation of iodine-131 labelled human growth hormone of high specific activity

Phospholipids containing polyunsaturated fatty acyl groups are mitogenic for normal mouse mammary epithelial cells in serum-free primary cell culture.

The primary structure of a membrane-associated phospholipase A2 from human spleen.

Breast cancer prognosis is poor when total plasminogen activator activity is low

Role of secretory phospholipases A2 in the pathobiology of disease.

Intracellular phospholipases A.

Membrane-associated phospholipase A2 stimulates DNA synthesis in two murine fibroblasts.

Lipid-dependent proliferation of pancreatic cancer cell lines.

P2888

P304

1166-1170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1994.229

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

1994-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15000253

http://www.w3.org/2001/XMLSchema#string

P698

8198986

http://www.w3.org/2001/XMLSchema#string

P921

P932

1969450

http://www.w3.org/2001/XMLSchema#string